Navigation Links
Gene Research Sheds Light on Lung Cancer Survival Time
Date:12/15/2010

WEDNESDAY, Dec. 15 (HealthDay News) -- Genes that predict length of survival and help guide treatment for patients with non-small cell lung cancer have been identified by U.S. researchers.

The investigators took samples of lung tumors and nearby healthy lung tissue from 30 patients and examined the samples for the presence of messenger ribonucleic acid (mRNA) associated with 48 known genes for molecules called nuclear hormone receptors.

They then compared the active genes with patient outcomes and found that the expression of genes for certain nuclear hormone receptors helped predict patient survival.

According to the results, patients with two specific nuclear hormone receptors in their tumor tissue lived the longest. The two "biomarkers" were the short heterodimer partner and the progesterone receptor.

"Patient responses to cancer treatment vary widely and often depend on subtle biological differences among tumors," study co-lead author Dr. David Mangelsdorf, chairman of pharmacology at the University of Texas Southwestern Medical Center, said in a facility news release.

"These findings are important because the ability to determine which genes are being expressed in each person's tumor, as well as a patient's likely survival time, can guide physicians to the most effective and appropriate personalized treatments," he added.

The study was published in the Dec. 14 edition of the journal PLoS Medicine.

More information

The American Cancer Society has more about non-small cell lung cancer.

-- Robert Preidt

SOURCE: University of Texas Southwestern Medical Center, news release, Dec. 14, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Breast inflammation is key to cancer growth, Kimmel Cancer Center researchers say
2. Genetic Research Sheds Light on Adrenal Gland Tumor Risk
3. Researchers discover new signaling pathway linked to inflammatory disease
4. UCI researchers find novel memory-enhancing mechanism in brain
5. Cancer Research Institute launches Cancer Vaccine Acceleration Fund
6. States Now Fund Most Embryonic Stem Cell Research in U.S.
7. Researchers make critical leukemia stem cell discovery
8. U-M researchers discover way to block neurodegeneration in an adult form of Fragile X syndrome
9. Leibniz Prize 2011: 10 researchers awarded €2.5 million ($3.3 million) each
10. Research tackles drug use, HIV in South African youth
11. Researchers Turn Stem Cells Into Intestinal Tissue in Lab
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Gene Research Sheds Light on Lung Cancer Survival Time
(Date:4/24/2017)... ... April 24, 2017 , ... Miami ... attending the 2017 Oral Reconstruction Foundation’s 2017 Symposium on Tissue Regeneration and Implant ... will present its annual Global Symposium at the Fontainebleau Hotel located in Miami ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... development of next generation neuro-thrombectomy systems for the treatment of Acute Ischemic Stroke ... its ANCD BRAIN device as the product advances towards regulatory and clinical phases. ...
(Date:4/23/2017)... ... April 23, 2017 , ... Altura ... the achievement of Cisco Select certification and SMB specialization. Altura is now ... , In earning the Select Certification, Altura fulfilled the training and exam ...
(Date:4/22/2017)... ... April 22, 2017 , ... ... consumers can save an average of 70% when buying medication online from Canadian ... are available when purchasing from other countries. The report (chart below) compares U.S. ...
(Date:4/21/2017)... ... April 21, 2017 , ... An April 10 article in ... teeth, which reveal a great deal about prehistoric ice-age dental practitioners and their primitive ... been used to remove decayed dental matter, and that teeth were then filled with ...
Breaking Medicine News(10 mins):
(Date:4/18/2017)... -- Cardinal Health (NYSE: CAH ) today is ... share (EPS) guidance and providing a preliminary view on ... this morning,s announcement of the planned acquisition of Medtronic,s ... Cardinal Health now believes that fiscal 2017 ... bottom of its previous guidance range of $5.35 to ...
(Date:4/18/2017)... -- Astute Medical, Inc., developer of biomarkers for better healthcare, ... the 2017 National Kidney Foundation (NKF) Spring Clinical ... 22. Physicians will present data on two biomarkers, ... acute kidney injury (AKI) during the management of patients ... Elevated levels of TIMP-2 and IGFBP-7 have been shown ...
(Date:4/18/2017)... , April 18, 2017  Spero Therapeutics, LLC, a ... treatment of bacterial infections, will present preclinical data supporting ... of multidrug resistant (MDR) Gram-negative infections at the 27th ... April 22-25, 2017 in Vienna, Austria ... ...
Breaking Medicine Technology: